Ian studied for his PhD at the University of Newcastle upon Tyne, eventually moving to NIBSC after periods of postdoctoral research in molecular genetics at the University of Sheffield and the Friedrich Miescher Institut in Basel. During the late 1990s, when new conjugate vaccines were being introduced, he headed the laboratory responsible for the control and standardisation of meningococcal and pneumococcal vaccines.
Ian continues to oversee an active research programme on the molecular genetics and immunology of meningococcal antigens. Because of his broad experience of bacterial vaccines and molecular biology, he has been closely involved with a number of meningococcal vaccine developments. He regularly contributes to WHO and EU guidelines, has been an advisor to the International Vaccine Institute’s typhoid conjugate vaccine initiative, and serves on the PHE’s invasive bacterial diseases forum. He is one of NIBSC’s observers on Joint Vaccination and Immunisation Committee (JCVI) and a member of the JCVI subgroups on meningococcal and pneumococcal vaccines. He is a former editor of the Journal of Applied Microbiology and is currently an associate editor of Human Vaccines and Immunotherapeutics.
He has over 100 publications most of which are peer reviewed research papers. Ian teaches on vaccine related courses in the University of London and at the University of Surrey, and is a Visiting Professor at Imperial College.